Liraglutide

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 72603-745
  • Package NDC 72603-745-02
  • Package NDC 72603-745-03
  • Application number ANDA218115
  • SPL ID 792c7fe2-ae5a-4867-a4de-8147efacc85e
  • SPL set ID 4253be3b-bda6-4efd-8118-9c9538168a88
  • UNII 839I73S42A
  • RxCUI 897122

What the source publishes

Labeler
NorthStar Rx LLC
Active ingredients
liraglutide
Form
INJECTION
Routes
SUBCUTANEOUS
Administrative status
present-in-source-snapshot
Marketing status
ANDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:72603-745_792c7fe2-ae5a-4867-a4de-8147efacc85e
{
  "name": "Liraglutide",
  "splId": "792c7fe2-ae5a-4867-a4de-8147efacc85e",
  "labels": [
    {
      "setId": "4253be3b-bda6-4efd-8118-9c9538168a88",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4253be3b-bda6-4efd-8118-9c9538168a88",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4253be3b-bda6-4efd-8118-9c9538168a88"
    }
  ],
  "routes": [
    "SUBCUTANEOUS"
  ],
  "labeler": "NorthStar Rx LLC",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "2 SYRINGE, PLASTIC in 1 CARTON (72603-745-02)  / 3 mL in 1 SYRINGE, PLASTIC (72603-745-01)",
      "package_ndc": "72603-745-02",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20260301"
    },
    {
      "sample": false,
      "description": "3 SYRINGE, PLASTIC in 1 CARTON (72603-745-03)  / 3 mL in 1 SYRINGE, PLASTIC (72603-745-01)",
      "package_ndc": "72603-745-03",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20260301"
    }
  ],
  "productId": "72603-745_792c7fe2-ae5a-4867-a4de-8147efacc85e",
  "useDomain": "unknown",
  "dosageForm": "INJECTION",
  "productNdc": "72603-745",
  "deaSchedule": null,
  "genericName": "liraglutide",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "LIRAGLUTIDE",
      "strength": "6 mg/mL"
    }
  ],
  "applicationNumber": "ANDA218115",
  "marketingCategory": "ANDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20260301",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000178480",
      "M0160181",
      "N0000020058"
    ],
    "upc": [
      "0372603745030",
      "0372603745016",
      "0372603745023"
    ],
    "unii": [
      "839I73S42A"
    ],
    "rxcui": [
      "897122"
    ],
    "spl_set_id": [
      "4253be3b-bda6-4efd-8118-9c9538168a88"
    ],
    "pharm_class_cs": [
      "Glucagon-Like Peptide 1 [CS]"
    ],
    "pharm_class_epc": [
      "GLP-1 Receptor Agonist [EPC]"
    ],
    "pharm_class_moa": [
      "Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]"
    ],
    "manufacturer_name": [
      "NorthStar Rx LLC"
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:72603-745_792c7fe2-ae5a-4867-a4de-8147efacc85e"